>
Wockhardt Bio AG logo

WBIO - Wockhardt Bio AG Share Price

CHF0.76 0.0  0.0%

Last Trade - 14/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £31.0m
Enterprise Value £10.6m
Revenue £n/a
Position in Universe th / 1048
Bullish
Bearish
Unlock WBIO Revenue
Momentum
Relative Strength (%)
1m -71.3%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
406.3 418 331.1 336.2 337 315.1 -5.0%
-71.4 -3.7
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2020, WockhardtBio AG revenues decreased 6% to $315.1M. Net income totaled$24.6M vs. loss of $23.5M. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Net Income reflects Otheroperating expense decrease of 21% to $73.7M (expense),Personnel expense decrease of 8% to $64M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

WBIO Revenue Unlock WBIO Revenue

Net Income

WBIO Net Income Unlock WBIO Revenue

Normalised EPS

WBIO Normalised EPS Unlock WBIO Revenue

PE Ratio Range

WBIO PE Ratio Range Unlock WBIO Revenue

Dividend Yield Range

WBIO Dividend Yield Range Unlock WBIO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
WBIO EPS Forecasts Unlock WBIO Revenue
Profile Summary

Wockhardt Bio AG is a Germany-based pharmaceutical company. It is active in the development, manufacturing and marketing of pharmaceutical and biopharmaceutical formulations. It offers a portfolio of generic drugs, which includes approximately 600 pharmaceuticals in various dosages and forms. Its offering covers several therapeutic categories, such as central nervous system agents, hormones, cardiovascular agents, anti-infective and respiratory agents, as well as gastrointestinal, dermatological and biological agents. The Company supplies markets in the United States, the United Kingdom, Ireland, France and Latin America. Additionally, it exports its pharmaceutical products to over 50 countries.

Directors
Last Annual March 31st, 2020
Last Interim March 31st, 2017
Incorporated October 17, 2005
Public Since December 19, 2013
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Berne eXchange
Shares in Issue 51,948,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
WBIO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for WBIO
Upcoming Events for WBIO
Frequently Asked Questions for Wockhardt Bio AG
What is the Wockhardt Bio AG share price?

As of 14/04/21, shares in Wockhardt Bio AG are trading at CHF0.76, giving the company a market capitalisation of £31.0m. This share price information is delayed by 15 minutes.

How has the Wockhardt Bio AG share price performed this year?

Shares in Wockhardt Bio AG are currently trading at CHF0.76 and the price has moved by -51.75% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Wockhardt Bio AG price has moved by -62.61% over the past year.

What are the analyst and broker recommendations for Wockhardt Bio AG?

There are no analysts currently covering Wockhardt Bio AG.

When will Wockhardt Bio AG next release its financial results?

Wockhardt Bio AG is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2018-03-31
What is the Wockhardt Bio AG dividend yield?

Wockhardt Bio AG does not currently pay a dividend.

Does Wockhardt Bio AG pay a dividend?

Wockhardt Bio AG does not currently pay a dividend.

When does Wockhardt Bio AG next pay dividends?

Wockhardt Bio AG does not currently pay a dividend.

How do I buy Wockhardt Bio AG shares?

To buy shares in Wockhardt Bio AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Wockhardt Bio AG?

Shares in Wockhardt Bio AG are currently trading at CHF0.76, giving the company a market capitalisation of £31.0m.

Where are Wockhardt Bio AG shares listed? Where are Wockhardt Bio AG shares listed?

Here are the trading details for Wockhardt Bio AG:

Country of listing: Switzerland
Exchange: BRN
Ticker Symbol: WBIO
What kind of share is Wockhardt Bio AG?

We were not able to load our ranking data for Wockhardt Bio AG

Is there a Wockhardt Bio AG share price forecast 2021?

We were not able to load any forecast data for Wockhardt Bio AG.

How can I tell whether the Wockhardt Bio AG share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Wockhardt Bio AG. Over the past six months, the relative strength of its shares against the market has been 22.77%. At the current price of CHF0.76, shares in Wockhardt Bio AG are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Wockhardt Bio AG PE Ratio?

We were not able to find PE ratio data for Wockhardt Bio AG.

Who are the key directors of Wockhardt Bio AG?

We were unable to find the directors for Wockhardt Bio AG.

Who are the major shareholders of Wockhardt Bio AG?

Here are the top five shareholders of Wockhardt Bio AG based on the size of their shareholding:

Similar to WBIO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.